Financial Performance - The company reported a revenue of 1.2 billion RMB for the first half of 2019, representing a year-on-year increase of 15% compared to the same period in 2018[1]. - The net profit attributable to shareholders for the first half of 2019 was 200 million RMB, an increase of 10% year-on-year[1]. - Future guidance indicates a revenue target of 2.5 billion RMB for the full year 2019, reflecting a growth rate of 20%[1]. - Total revenue for the reporting period was ¥267,484,176.54, an increase of 3.96% compared to ¥257,303,345.98 in the same period last year[20]. - The company’s operating revenue for the reporting period was RMB 267,484,176.54, representing a year-on-year increase of 3.96% compared to RMB 257,303,345.98[64]. - The company reported a net profit margin of 10% for the first half of 2019, indicating improved operational efficiency[93]. - The total comprehensive income for the first half of 2019 was ¥11,160,739.86, compared to a loss of ¥26,561,734.71 in the first half of 2018, indicating a positive shift in overall financial health[177]. - The company reported a total comprehensive income of RMB 26,561,734 for the current period, reflecting a significant change compared to the previous period[197]. User Growth and Market Expansion - User data showed a growth of 25% in active users, reaching 5 million by the end of June 2019[1]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by 2021[1]. - The company is actively pursuing market expansion strategies, particularly in the southern regions of China, aiming to increase market share by 15%[93]. - The company serves over 600,000 enterprises and has a product service reach of over 450 million people across more than 20 provinces[28]. - The company has expanded its health data product offerings to optimize existing medical insurance data support structures, responding to market demands with iterative development[32]. Research and Development - The company emphasized its commitment to R&D, with an investment of 150 million RMB planned for the next fiscal year to drive innovation[1]. - The company’s research and development investment increased by 45.42% to RMB 69,564,399.68, up from RMB 47,835,745.13 in the previous year[65]. - Research and development expenses increased to CNY 57,576,484.18, representing a 33.5% rise from CNY 43,192,221.08 in the previous year[170]. - The company is facing technology risks due to the rapid evolution of software and information technology products, necessitating continuous R&D efforts to meet market demands[97]. Strategic Initiatives - The company is actively pursuing strategic acquisitions to enhance its technology capabilities, with a budget of 500 million RMB allocated for potential targets[1]. - A strategic acquisition of a smaller tech firm is in progress, expected to enhance the company's service offerings and market presence[92]. - The company is committed to becoming a leading comprehensive operator of livelihood information services in China, integrating traditional services with internet innovations[38]. - The company has adopted an open platform strategy since 2017, focusing on health data and participating in the standardization of electronic health cards[36]. Financial Health and Assets - The total assets at the end of the reporting period were ¥1,923,514,411.41, reflecting a slight increase of 0.45% from ¥1,914,957,108.71 at the end of the previous year[20]. - The net assets attributable to shareholders decreased by 2.05% to ¥725,430,735.85 from ¥740,647,483.83 at the end of the previous year[20]. - The company’s cash and cash equivalents decreased by 38.23% compared to the beginning of the year, mainly due to net cash outflow from operating activities[42]. - The company’s total equity attributable to shareholders decreased by 4,755,850.68 CNY during the reporting period[186]. Operational Efficiency - The company’s operating costs decreased by 7.73% to RMB 127,057,591.47, down from RMB 137,699,669.46 in the previous year[65]. - The company reported cash inflow from operating activities amounted to ¥359,478,913.29, an increase from ¥349,280,213.77 in the previous year, reflecting improved operational efficiency[179]. - The net cash flow from operating activities was negative at ¥186,017,190.37, worsening from a negative cash flow of ¥129,428,854.52 in the first half of 2018[180]. Governance and Management - The company has established a governance structure including a shareholder meeting, board of directors, and supervisory board to enhance operational efficiency[199]. - The company appointed a new general manager and vice general manager during the reporting period, with changes effective from June 4, 2019[133]. - The company plans to establish a new management structure with a model of "company holding + core team equity participation" to enhance management quality and decision-making capabilities[100]. Risks and Challenges - The company identified potential risks related to regulatory changes and market competition, with strategies in place to mitigate these risks[1]. - The company anticipates increased competition in the internet medical sector, which may adversely affect business development, but it aims to leverage existing advantages to mitigate market risks[98]. - The company has implemented measures to mitigate operational risks, including a comprehensive after-sales service system to enhance brand reputation[97].

Financial Performance - Total revenue for Q1 2019 was CNY 105,820,606.40, representing an increase of 18.89% compared to CNY 89,009,549.04 in the same period last year[7]. - Net profit attributable to shareholders was CNY -20,827,377.48, a decrease of 3.28% from CNY -20,165,435.64 year-on-year[7]. - Basic and diluted earnings per share were both CNY -0.0484, a decrease of 3.20% from CNY -0.0469 in the same period last year[7]. - The company's operating profit was -27.78 million, a decrease of 15.92% year-on-year[19]. - Net profit for the current period was a loss of ¥26,208,038.73, compared to a loss of ¥20,906,837.22 in the previous period, worsening by about 25.4%[49]. - Operating profit for the current period was a loss of ¥27,784,518.76, compared to a loss of ¥23,968,296.76 in the previous period, reflecting a decline of approximately 15.1%[49]. - Total comprehensive loss for the current period was ¥26,208,038.73, compared to a loss of ¥20,906,837.22 in the previous period, indicating an increase in losses of about 25.4%[50]. Cash Flow - Net cash flow from operating activities was CNY -122,909,482.46, reflecting a decline of 25.54% compared to CNY -97,904,388.14 in the previous year[7]. - Total cash inflow from operating activities was 133,405,531.01 CNY, while cash outflow was 256,315,013.47 CNY, resulting in a net cash flow deficit[57]. - Cash flow from investing activities showed a net outflow of -5,036,043.18 CNY, compared to -1,393,395.94 CNY in the previous period, reflecting increased investment expenditures[58]. - Cash inflow from financing activities was 91,000,000.00 CNY, with a net cash flow of 45,204,889.53 CNY, a significant increase from 4,945,818.71 CNY in the previous period[58]. - The ending balance of cash and cash equivalents decreased to 243,040,610.00 CNY from 311,289,735.85 CNY, indicating a reduction in liquidity[58]. - The company received 90,150,000.00 CNY from borrowings, up from 80,000,000.00 CNY in the previous period, showing reliance on debt financing[62]. - Total cash inflow from operating activities was 105,759,629.46 CNY, down from 182,858,402.94 CNY, indicating a decline in revenue generation[61]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,915,622,997.37, a slight increase of 0.03% from CNY 1,914,957,108.71 at the end of the previous year[7]. - Current liabilities totaled CNY 808,432,841.84, up from CNY 781,284,873.36, reflecting an increase of approximately 3.9%[40]. - The company's total liabilities reached CNY 1,107,530,164.59, an increase from CNY 1,081,506,237.20, marking a growth of about 2.3%[40]. - Total liabilities reached CNY 1,081,506,237.20, with current liabilities at CNY 781,284,873.36[65]. - The company’s retained earnings were reported at CNY 250,158,960.13[65]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,281[10]. - The top shareholder, Zhang Xi, holds 16.21% of the shares, amounting to 69,681,649 shares, with 52,261,237 shares pledged[10]. - Micro Medical Group increased its shareholding to 41,200,000 shares, representing 9.58% of the total share capital as of March 31, 2019, up from 21,000,000 shares or 4.88% prior to the increase[29]. - The company’s major shareholder, Zhang Xi, retained 128,875,867 shares, accounting for 29.97% of the total share capital after the transfer of 36,775,000 shares[26]. - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11]. Operational Highlights - The company plans to enhance its core competitiveness through continuous R&D of new technologies and products[22]. - The company is actively expanding its business in the healthcare sector, public services, and big data fields to increase market share[19]. - The company has implemented measures to mitigate technology risks, including patent applications and internal confidentiality systems[22]. - Research and development expenses rose to ¥29,615,998.59, up from ¥23,188,014.68, indicating a growth of approximately 27.7%[47]. Other Financial Metrics - Other receivables increased by 49.15% compared to the beginning of the year, mainly due to new factoring business interest[17]. - Inventory increased by 48.24% compared to the beginning of the year, primarily due to the increase in project equipment[17]. - Investment income increased by 61.79% year-on-year, mainly due to profits from certain affiliated companies[18]. - Other income increased to ¥4,733,035.81 from ¥1,856,697.74, marking a growth of about 154%[47]. - The company incurred financial expenses of ¥3,551,134.28, down from ¥4,500,865.83, a decrease of approximately 21%[47].

Financial Performance - The company's operating revenue for 2018 was ¥729,805,790.24, representing a 16.67% increase compared to ¥625,540,124.27 in 2017[17]. - The net profit attributable to shareholders for 2018 was ¥14,664,775.38, a decrease of 19.08% from ¥18,121,725.29 in the previous year[17]. - The net cash flow from operating activities reached ¥56,774,366.09, a significant increase of 6,163.56% compared to -¥936,320.35 in 2017[17]. - The total assets at the end of 2018 were ¥1,914,957,108.71, showing a slight increase of 0.25% from ¥1,910,237,184.55 at the end of 2017[17]. - The net assets attributable to shareholders increased by 1.84% to ¥740,647,483.83 at the end of 2018, compared to ¥727,272,623.62 at the end of 2017[17]. - The basic earnings per share for 2018 was ¥0.0340, down 19.05% from ¥0.0420 in 2017[17]. - The company reported a total of ¥8,245,989.04 in non-recurring gains and losses for 2018, compared to ¥60,964,213.70 in 2017[23]. - The company's total revenue for 2018 reached approximately 1.1 billion yuan, with a significant increase in the fourth quarter due to project completions[62]. - The net profit attributable to shareholders for the fourth quarter was approximately 31.8 million yuan, marking a recovery from previous losses in earlier quarters[62]. - The company reported a total revenue of 1,724,181,890 for the year, with a net profit of 272,409,605, indicating a profit margin of approximately 15.8%[96]. Dividend Distribution - The company plans to distribute a cash dividend of 0.05 CNY per 10 shares to all shareholders, based on a total of 430,000,000 shares[4]. - The cash dividend distribution accounted for 100% of the profit distribution total, aligning with the company's policy of distributing at least 80% of profits during mature stages[119]. - In 2018, the cash dividend amount was CNY 2,150,000, representing 14.66% of the net profit attributable to ordinary shareholders[122]. - In 2017, the cash dividend amount was CNY 2,150,000, which accounted for 11.86% of the net profit attributable to ordinary shareholders[122]. - In 2016, the cash dividend amount was CNY 2,150,000, making up 20.29% of the net profit attributable to ordinary shareholders[122]. - The company maintained a consistent cash dividend policy over the past three years, with each year distributing 2,150,000 yuan[120]. Operational Strategy - The company plans to continue focusing on technological innovation and market expansion in the upcoming year[24]. - The company aims to leverage the government's focus on health care informationization to enhance its market position and expand its services[30]. - The company is actively exploring the integration of new technologies like cloud computing and big data into its health service offerings[27]. - The company aims to leverage big data to enhance its service offerings in healthcare and social security sectors, focusing on disease outbreak warnings and employment decision analysis[38]. - The company is focusing on integrating its core business areas, including healthcare, social security, and big data, to enhance its competitive advantage[49]. - The company plans to continue exploring new service models in the public service sector, particularly in the integration of internet services with social security[54]. - The company aims to achieve a net profit margin of 10% by optimizing operational efficiencies and reducing costs[95]. Market Presence and Expansion - The company serves over 450 million individuals and more than 6 million enterprises across over 20 provinces in China[25]. - The company has established a strong presence in the health care sector, offering solutions such as smart hospital systems and health city solutions[31]. - The company has expanded its services to over 20 provinces and 100 cities, serving a population of more than 450 million[46]. - The company is focused on expanding its market presence in the healthcare and public service sectors, aiming to optimize service delivery and cost efficiency[99]. - The company plans to expand its market presence in southern China, targeting a 15% increase in market share by the end of the next fiscal year[95]. Research and Development - Research and development expenses amounted to ¥105,432,970.39, an increase of 11.01% compared to the previous year, primarily due to rising labor costs[77]. - The company invested ¥118,360,835.88 in R&D, which is 16.22% of its operating revenue, with capitalized R&D expenses of ¥12,927,865.49, accounting for 10.92% of total R&D expenses[78]. - In 2019, the company plans to increase R&D investment and enhance R&D efficiency to strengthen its competitive advantage and explore new business breakthroughs[103]. Compliance and Governance - The company has established a complete independent labor, personnel, and salary management system[126]. - The commitments regarding related party transactions have been strictly adhered to, with no violations reported[124]. - The company has taken measures to prevent conflicts of interest and ensure fair transactions[125]. - The company has committed to maintaining its independence and ensuring that key management personnel do not hold positions in other controlled enterprises[126]. - The company has established an independent financial department and accounting system, allowing for autonomous financial decision-making[128]. Technology and Innovation - The company has developed a comprehensive software and hardware application system, integrating online and offline services, driven by big data[25]. - The company has pioneered several industry-first innovations, including the first financial social security IC card and the first cloud computing platform for public service in the industry[42]. - The company is actively involved in the development of a "Internet + Healthcare" platform, with significant contracts signed in 2018[51]. - The company has launched several new products, including "Internet + Healthcare" services and big data integration platforms, to enhance its service offerings[100]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, indicating potential risks and countermeasures in its operational outlook[4]. - The company is committed to enhancing its internal control system and risk prevention mechanisms to ensure stable operations[104]. - The company faces technology risks due to rapid changes in software and information technology, necessitating continuous R&D and product upgrades[106]. Shareholder Information - The company’s total share capital is 430,000,000 shares, with 376,521,705 shares being unrestricted[193]. - The largest shareholder, Zhang Xi, holds 16.21% of the shares, totaling 69,681,640 shares, with a pledge status on 69,606,549 shares[199]. - The company has a significant number of shares pledged, with Zhang Xi pledging 17,420,412 shares and Xiamen Linzhen Trading Co., Ltd. pledging 22,419,218 shares[198]. - The company’s major shareholders are primarily natural persons, with Zhang Xi being the controlling shareholder[200].

Financial Performance - Operating revenue for the reporting period was ¥180,644,547.52, representing a year-on-year increase of 56.64%[7] - Net profit attributable to shareholders was ¥3,418,720.05, a significant increase of 129.80% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥3,125,656.01, up 122.13% year-on-year[7] - Basic earnings per share for the reporting period was ¥0.0080, reflecting a 129.96% increase compared to the same period last year[7] - The company's operating revenue increased by 40.44% compared to the same period last year, driven by business growth[18] - Total operating revenue for Q3 2018 was CNY 180.64 million, an increase of 56.5% compared to CNY 115.33 million in the same period last year[34] - Net profit for Q3 2018 was CNY 8.34 million, compared to a net loss of CNY 10.67 million in Q3 2017, marking a significant turnaround[36] - The net loss attributable to the parent company for the year-to-date was CNY -17,159,190.55, compared to a loss of CNY -52,530,467.36 in the previous year[45] Cash Flow - The company reported a net cash flow from operating activities of -¥174,175,578.72, a decline of 2.22% year-to-date[7] - Cash inflow from operating activities totaled ¥518,420,202.70, while cash outflow was ¥692,595,781.42, resulting in a negative cash flow[49] - Cash and cash equivalents decreased by 34.32% from the beginning of the year, primarily due to net cash outflows from operating activities[20] - Cash inflow from financing activities totaled ¥450 million, with ¥165 million from borrowings and ¥176 million from other financing activities[55] - The net increase in cash and cash equivalents was -¥121 million, compared to -¥14.8 million in the previous period[55] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,915,610,029.85, an increase of 0.28% compared to the end of the previous year[7] - The company's total assets amounted to approximately CNY 1.92 billion as of September 30, 2018[28] - The total liabilities decreased to CNY 939.16 million from CNY 971.64 million, a reduction of about 3.3%[32] - The equity attributable to shareholders of the parent company decreased to CNY 707.96 million from CNY 727.27 million, a decline of 2.6%[32] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,373[10] - The top shareholder, Zhang Xi, holds 16.21% of the shares, amounting to 69,681,649 shares, with 52,261,237 shares pledged[11] Operating Costs and Expenses - Operating costs rose by 43.92% year-on-year, primarily due to increased costs associated with system integration and hardware business[18] - Total operating costs for Q3 2018 were CNY 178.35 million, up 36.7% from CNY 130.46 million in the previous year[34] - The company's total operating expenses increased, with research and development expenses at ¥3,253,997.69, down from ¥13,328,846.79 in the previous period[47] Research and Development - Development expenditures rose by 130.41% from the beginning of the year, reflecting increased investment in research and development[20] - The company reported a significant increase in research and development expenses, totaling CNY 24.60 million, compared to CNY 41.16 million in the previous year, indicating a focus on innovation despite the reduction[34] Non-Recurring Gains and Losses - The company recorded non-recurring gains of ¥5,713,677.15 during the reporting period[8] - The company reported an increase of 101.37% in other income year-on-year, primarily due to increased government subsidies[20] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[36]

Financial Performance - The company reported a revenue of 300 million RMB for the first half of 2018, representing a year-on-year increase of 15% compared to the same period in 2017[14]. - The net profit attributable to shareholders for the first half of 2018 was 50 million RMB, an increase of 10% year-on-year[14]. - Total revenue for the reporting period was ¥257,303,345.98, representing a 30.94% increase compared to ¥196,502,502.16 in the same period last year[19]. - Net profit attributable to shareholders was -¥20,577,910.60, an improvement of 49.88% from -¥41,057,967.09 year-on-year[19]. - The company achieved a revenue of 257.30 million yuan in the first half of 2018, representing a year-on-year increase of 30.94%[42]. - The company's operating profit was -23.26 million yuan, showing a year-on-year improvement of 53.79%[42]. - The net loss for the first half of 2018 was CNY 19,429,641.17, compared to a net loss of CNY 41,218,772.04 in the same period of 2017, indicating an improvement in performance[158]. Investment and R&D - The company plans to invest 20 million RMB in research and development for new technologies and products in the upcoming year[14]. - The company’s development expenditure increased by 68.94%, reflecting increased investment in research and development[36]. - The company's R&D investment increased by 33.43% to ¥47,835,745.13, reflecting a commitment to enhancing research activities[48]. - Continuous investment in technology and product development is crucial for the company's growth, with a focus on maintaining a leading position in core technologies[72]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting three new provinces by the end of 2019[14]. - The company is exploring potential mergers and acquisitions to enhance its market position and service offerings[14]. - The company is focusing on strategic upgrades driven by big data in health care, public services, and industrial finance[26]. - The company aims to enhance product technology and service quality while increasing market promotion efforts[30]. - The company is actively exploring new technologies such as big data, blockchain, and biometric identification to enhance its service offerings[42]. User and Service Growth - User data showed a growth of 25% in active users, reaching 1.5 million by the end of June 2018[14]. - The company serves over 450 million people and more than 6 million enterprises across more than 20 provinces[26]. - The company has expanded its services to over 450 million people across more than 100 cities in over 20 provinces[40]. - The company has established internet medical project teams to expand into the internet healthcare sector, including smart hospitals and remote medical services[29]. Financial Position and Assets - Total assets at the end of the reporting period were ¥1,955,587,673.14, up 2.37% from ¥1,910,237,184.55 at the end of the previous year[19]. - The company's total assets at the end of the period amounted to RMB 632,149,102.15, an increase from the beginning balance[182]. - The company's current assets totaled RMB 1,363,788,695.03, compared to RMB 1,311,172,759.03 at the start of the period, reflecting a growth of approximately 4%[148]. - The company's total liabilities were RMB 1,196,830,114.06, up from RMB 1,142,219,984.30, indicating a rise of about 4.8%[149]. Shareholder and Equity Information - No cash dividends or stock bonuses will be distributed to shareholders for this period[5]. - The company did not distribute cash dividends or issue new shares from capital reserves during the reporting period[79]. - The total number of shares outstanding is 430,000,000, with 12.44% being limited shares and 87.56% being unrestricted shares[126]. - The company has a total of 10 major shareholders, with no new strategic investors or general corporate entities becoming major shareholders during the reporting period[131]. Risks and Challenges - The company is facing risks related to market competition and regulatory changes, with strategies in place to mitigate these risks[4]. - The company is facing increased competition in the internet healthcare sector, prompting a strategic push to enhance its core competitive advantages[73]. - The company is facing human resource risks due to high employee turnover and competition for skilled talent, which could impact operations[74]. Corporate Governance and Compliance - The company has not experienced any penalties or corrective actions during the reporting period[87]. - The company has no major litigation or arbitration matters during the reporting period[84]. - The financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring compliance and accuracy[186]. Subsidiaries and New Ventures - The company established a new subsidiary, Haibao Life Insurance Co., Ltd., which has commenced operations during the reporting period, enhancing its financial service offerings[44]. - The company has established Fujian Yilianzhong Yidaxun Education Technology Co., Ltd. with a registered capital of RMB 50 million, where the company contributed RMB 32.5 million (65%) and the vice president contributed RMB 17.5 million (35%)[94]. - The company also set up Yilianzhong Liankang (Xiamen) Information Technology Co., Ltd. with a registered capital of RMB 5 million, with the company investing RMB 3.25 million (65%) and the vice president investing RMB 1.75 million (35%)[95].

Financial Performance - Total revenue for Q1 2018 was ¥89,009,549.04, representing a 59.23% increase compared to ¥55,901,365.53 in the same period last year[7] - Net profit attributable to shareholders was -¥20,165,435.64, an improvement of 17.87% from -¥24,553,950.44 year-on-year[7] - The company's revenue increased by 59.23% compared to the same period last year, primarily due to the expansion of business scale in software and IC card operations, as well as in the human resources industry[21] - The net profit attributable to shareholders was -20.17 million RMB, an increase of 17.87% year-on-year[23] - The net profit for the current period was a loss of ¥20,906,837.22, an improvement from a loss of ¥24,488,182.21 in the previous period[49] - The net profit for Q1 2018 was a loss of ¥13,313,871.79, slightly improved from a loss of ¥13,574,549.87 in Q1 2017, indicating a reduction in losses of about 1.9%[52] Cash Flow - The net cash flow from operating activities was -¥97,904,388.14, a slight decrease of 3.00% compared to -¥95,051,593.03 in the previous year[7] - The net cash flow from operating activities decreased by 2.85 million RMB compared to the same period last year, mainly due to a reduction in receivables collection and an increase in payments to suppliers[21] - The cash flow from operating activities showed a net outflow of ¥97,904,388.14, compared to a net outflow of ¥95,051,593.03 in the previous year, reflecting a deterioration of approximately 3%[55] - The company reported a significant increase in cash paid for operating activities, totaling 100,581,065.47 CNY, compared to 269,493,943.58 CNY in the previous year[59] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,862,998,128.93, down 2.47% from ¥1,910,237,184.55 at the end of the previous year[7] - The net assets attributable to shareholders decreased by 2.77% to ¥707,107,187.98 from ¥727,272,623.62 at the end of the previous year[7] - The company's total equity was CNY 755,855,363.03, down from CNY 768,017,200.25, reflecting a decrease of about 1.6%[42] - The total liabilities increased to ¥1,013,953,318.01 from ¥971,643,348.36, indicating a rise in financial obligations[45] Shareholder Information - As of the end of the reporting period, the total number of common stock shareholders was 24,814[14] - The largest shareholder, Zhang Xi, holds 16.21% of the shares, amounting to 69,681,649 shares, with 52,261,237 shares pledged[14] - The top 10 shareholders collectively hold significant stakes, with the second-largest shareholder holding 8.55%[14] - The company has a total of 53,478,295 restricted shares, with specific release conditions for executives[18] Operational Strategy - The company faces technology risks due to rapid updates in software and product lifecycles, necessitating continuous R&D efforts[9] - The company is actively upgrading to an internet operation model to maintain its leading position in the industry, which involves significant investment and time[11] - The company has established a comprehensive after-sales service system to enhance its brand image and address operational risks[9] - The company is focusing on enhancing its core technology competitiveness through increased investment in talent and R&D[11] - The company has implemented a new management structure to improve operational flexibility and control over strategic direction and risks[12] - The company plans to continue expanding its business and exploring new technologies in the upcoming quarters[21] - The company is actively expanding its business in healthcare, public services, and big data sectors to enhance its competitive advantage[22] Financial Activities - The net cash flow from investing activities decreased by 74.26% year-on-year, primarily due to reduced investments in associated companies[21] - The net cash flow from financing activities increased by 22.1% compared to the same period last year, mainly due to increased investments from minority shareholders[21] - The financing activities generated a net cash inflow of ¥4,945,818.71 in Q1 2018, compared to ¥4,050,725.00 in Q1 2017, reflecting an increase of approximately 22.1%[56] - The company incurred financial expenses of ¥4,095,120.56 in Q1 2018, significantly higher than ¥528,993.84 in Q1 2017, marking an increase of about 675%[51] Compliance and Governance - The company has no overdue commitments from shareholders or related parties during the reporting period[32] - There were no violations regarding external guarantees during the reporting period[34] - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties[35] - The company is in compliance with its profit distribution policy as per its articles of association[33]

Dividend Distribution - The company plans to distribute a cash dividend of 0.05 RMB per 10 shares to all shareholders, based on a total of 430,000,000 shares[4]. - The cash dividend accounted for 100% of the total profit distribution for the year[107]. - The cash dividend for 2017 represented 11.86% of the net profit attributable to shareholders[111]. - The company has consistently distributed a cash dividend of 2,150,000 yuan for the years 2015, 2016, and 2017[110]. - The independent directors confirmed the compliance and clarity of the dividend distribution process[107]. Financial Performance - The company's operating revenue for 2017 was ¥625,540,124.27, representing a 21.54% increase compared to ¥514,673,328.92 in 2016[15]. - The net profit attributable to shareholders for 2017 was ¥18,121,725.29, a significant increase of 70.99% from ¥10,598,174.34 in 2016[15]. - The company reported a total revenue of 1.2 billion RMB for the year ending December 31, 2017, reflecting a year-on-year growth of 15%[113]. - The gross profit margin improved to 45%, up from 40% in the previous year, indicating better cost management[113]. - The company reported a net profit of ¥27,216,305.58 for the year 2017, compared to ¥9,903,571.10 in the previous year, indicating a significant increase in profitability[127]. Risk Management and Governance - The report emphasizes the importance of risk awareness regarding future plans and performance forecasts, highlighting the potential risks and countermeasures in the company's future development outlook[4]. - The company has a structured governance framework, including a board of directors and a supervisory board, ensuring compliance with regulatory requirements[4]. - The company has implemented a performance assessment mechanism for subsidiaries to enhance financial control and risk management[47]. - The company is committed to strengthening its internal control system and external risk prevention mechanisms to ensure stable organizational operations[97]. - The company recognizes the risk of technology obsolescence and is focused on continuous R&D to meet market demands and maintain its competitive edge[97]. Market Expansion and Strategic Initiatives - The company has a focus on expanding its market presence through various subsidiaries and strategic partnerships in the technology sector[9]. - The company is actively exploring new product research and development, as well as the application of new technologies to enhance its core competitiveness[36]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2019[117]. - The company aims to enhance market expansion by leveraging its advantages in basic, platform, channel, and payment services, focusing on the integration and upgrade of healthcare services[95]. - The company is strategically positioned to leverage the growth of internet healthcare, aiming to enhance its core competitive advantages to mitigate market risks[98]. Research and Development - The company has increased its R&D investment, launching multiple new products in the smart terminal category[25]. - In 2017, the company's R&D investment amounted to ¥106.63 million, representing 17.05% of total revenue[64]. - The number of R&D personnel increased to 1,049 in 2017, making up 50.55% of the total workforce[65]. - The company is investing 100 million RMB in R&D for new technologies aimed at improving service efficiency and user experience[119]. - The company aims to reduce operational costs by 8% in 2018 through process optimization and automation[120]. Subsidiaries and Acquisitions - The company has established 9 new entrepreneurial subsidiaries from 2016 to 2017, with most achieving profitability in 2017[45]. - The company acquired Hainan Yilianzhong Information Technology Co., Ltd. during the reporting period, enhancing its market presence[59]. - The company established several entrepreneurial subsidiaries in 2018, including Fujian Yilianzhong Medical Information Technology Co., Ltd. with a registered capital of 5,000,000 RMB, focusing on grassroots health care[186]. - The company has a registered capital of 100,000,000 CNY for its subsidiary Xiamen Yilianzhong Financial Holdings Co., Ltd., which reported a net profit of 11,227,746.8 CNY[88]. - The company aims to leverage its advantages in medical information technology to develop a health management platform for grassroots medical reform and family doctor services[186]. Financial Management and Investments - The company reported a significant difference between net cash flow from operating activities and net profit due to an increase in operating receivables[69]. - The company has taken measures to optimize its asset management and reduce costs[82]. - The company has implemented a cash dividend policy, distributing a cash dividend of 0.05 yuan per 10 shares, totaling 2,150,000 yuan for the year 2016[106]. - The company received government subsidies amounting to ¥11,015,953.84, which were adjusted to be reported as other income[125]. - The company plans to apply for accounts receivable factoring business with a financing limit of RMB 50 million to meet working capital needs[163]. Shareholder Structure and Control - The company’s major shareholder, Zhang Xi, holds 52,261,236 shares, with 9,219,861 shares subject to trading restrictions[193]. - Zhang Xi became the controlling shareholder on December 18, 2017, indicating a shift in ownership structure[199]. - The company has maintained a stable shareholder structure with no significant changes in the top ten shareholders' positions[198]. - The actual controller of the company is Zhang Xi, a natural person from China[200]. - The company has disclosed its ownership and control relationship with the actual controller on the designated website, cninfo.com.cn[200].

Financial Performance - Operating revenue for the reporting period was ¥115,328,073.04, reflecting a year-on-year growth of 21.37%[7] - Net profit attributable to shareholders was -¥11,472,500.27, a decrease of 4.69% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥14,127,201.82, down 22.80% year-on-year[7] - Basic earnings per share were -¥0.0267, a decline of 4.71% compared to the previous year[7] - The weighted average return on net assets was -1.75%, a decrease of 0.19% from the previous year[7] - Net profit for Q3 2017 was a loss of CNY 10,666,904.82, compared to a loss of CNY 11,965,166.94 in the same period last year[34] - Net profit for the period was CNY 63,445,967.48, a significant recovery from a net loss of CNY 2,519,297.72 in the same period last year[38] - The company's operating revenue for the current period was ¥128,866,156.83, an increase of 10.5% compared to ¥116,827,763.73 in the previous period[45] - Operating profit reached ¥41,895,977.93, a significant improvement from a loss of ¥17,442,650.22 in the previous period[46] - Net profit for the current period was ¥49,483,668.54, compared to a net loss of ¥11,713,645.99 in the previous period, indicating a turnaround in profitability[46] Cash Flow and Liquidity - The net cash flow from operating activities was -¥170,391,454.97, down 30.08% year-on-year[7] - Cash and cash equivalents decreased by 32.52% compared to the beginning of the year, primarily due to net cash outflow from operating activities[16] - The cash flow from operating activities generated a net amount of ¥132,857,243.86, a recovery from a negative cash flow of ¥20,979,803.53 in the previous period[51] - The company reported a total cash inflow from operating activities of ¥795,526,513.48, up from ¥409,195,423.61 in the previous period[51] - The total cash and cash equivalents at the end of the period were ¥229,144,597.15, compared to ¥182,889,500.16 at the end of the previous period[50] - The net cash flow from financing activities was 43,506,350.91 CNY, compared to 92,806,269.23 CNY in the previous period, indicating a decrease of approximately 53%[52] - The ending balance of cash and cash equivalents was 28,094,399.80 CNY, down from 42,861,637.31 CNY at the beginning of the period, reflecting a decrease of approximately 34%[52] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,836,006,857.97, an increase of 29.39% compared to the previous year[7] - Total liabilities reached CNY 848,898,483.32, compared to CNY 581,986,021.73 at the start of the period[31] - The company's total equity was CNY 591,258,067.54, up from CNY 543,924,399.00 at the beginning of the period[31] - Cash and cash equivalents decreased to CNY 37,624,795.80 from CNY 52,059,133.31[28] - Accounts receivable decreased to CNY 181,035,641.44 from CNY 191,211,152.25[28] - Inventory increased to CNY 32,884,509.21 from CNY 27,602,624.66[28] - Long-term equity investments rose significantly to CNY 919,492,098.55 from CNY 422,584,967.11[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,576[11] - The largest shareholder, Zhang Xi, held 13.35% of the shares, amounting to 57,388,500 shares, with 43,041,375 shares pledged[11] Non-Recurring Items and Other Gains - The company reported a total of ¥3,522,727.19 in non-recurring gains and losses for the year-to-date[8] - The company reported a significant increase in investment income, amounting to ¥90,827,931.44, compared to ¥541,423.99 in the previous period[45] Strategic Initiatives - The company signed a strategic cooperation framework agreement with Tencent to enhance information technology in the social security and healthcare sectors[19] Operational Costs - Total operating costs for Q3 2017 amounted to CNY 130,464,775.71, up from CNY 108,386,330.58 year-over-year[34] - Total operating costs increased to CNY 373,650,164.33, up from CNY 297,281,887.79, reflecting a rise in operating expenses[40] - Sales expenses rose to CNY 40,936,151.61, compared to CNY 24,052,278.74 in the previous period, indicating increased marketing efforts[40] - Management expenses were reported at CNY 145,512,596.18, up from CNY 114,270,601.82, reflecting higher operational costs[40] Development and Investment - Development expenditures increased by 161.36% compared to the beginning of the year, mainly due to increased R&D investment[18] - Goodwill increased by 1375.98% compared to the beginning of the year, primarily due to the acquisition of Hainan Yilianzhong[18]

Financial Performance - Total revenue for the reporting period was ¥196,502,502.16, representing a 5.37% increase compared to ¥186,483,274.32 in the same period last year[18]. - Net profit attributable to shareholders was -¥41,057,967.09, a significant decrease of 3,338.87% from ¥1,267,663.11 in the previous year[18]. - The net cash flow from operating activities was -¥124,824,310.84, which is a 43.96% decline compared to -¥86,707,836.31 in the same period last year[18]. - Basic earnings per share were -¥0.0955, down 3,393.10% from ¥0.0029 in the previous year[18]. - The company reported a significant increase in sales expenses by 78.84% due to increased marketing investments and employee compensation[41]. - The company reported an operating profit loss of CNY 50.33 million, worsening from a loss of CNY 4.62 million in the prior year[144]. - The total profit loss for the period was CNY 46.64 million, compared to a loss of CNY 0.88 million in the same period last year[144]. - The company reported a net loss of CNY 2,150,000 for the period, reflecting a significant decline in profitability[159]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,466,170,416.23, an increase of 3.32% from ¥1,418,991,298.46 at the end of the previous year[18]. - Current liabilities rose to CNY 750,381,932.67, compared to CNY 673,716,491.99, indicating an increase of about 11.4%[136]. - The total liabilities increased to CNY 759,170,590.30 from CNY 674,222,700.49, marking an increase of about 12.6%[136]. - The equity attributable to shareholders decreased to CNY 668,518,043.28 from CNY 711,726,010.37, a decline of approximately 6.1%[137]. - The total owner's equity decreased to CNY 706,999,825.93 from CNY 744,768,597.97, a decline of about 5.1%[137]. Cash Flow - Cash and cash equivalents decreased by 32.68% compared to the beginning of the year, mainly due to net cash outflow from operating activities[29]. - Cash received from operating activities amounted to CNY 252.99 million, compared to CNY 116.18 million in the previous period, showing a substantial increase[151]. - The net cash flow from investment activities was -66,280,768.70 CNY, indicating a higher investment outflow compared to the previous period's -135,808.15 CNY[152]. - The total cash inflow from financing activities was 259,100,000.00 CNY, while cash outflow was 184,476,005.85 CNY, resulting in a net cash flow of 74,623,994.15 CNY[153]. Investments and R&D - Research and development investment reached CNY 35.85 million, a 4.05% increase compared to the previous year[41]. - The company is actively developing big data applications in health care and human resources, establishing a data service management platform[37]. - The company has initiated the construction of the Fujian Provincial Big Data Trading Center to enhance its big data business capabilities[37]. - Development expenditures increased by 150.2% compared to the beginning of the year, mainly due to increased investment in research and development[29]. Market Presence and Strategy - The company serves over 300 million people across 21 provinces and more than 100 cities, indicating a significant market presence[32]. - The company has developed a comprehensive service model integrating online and offline operations, enhancing its competitive advantage in the public service sector[30]. - The company is focusing on the development of internet healthcare services, leveraging its existing advantages in the healthcare sector to mitigate market risks[66]. - The company plans to focus on market expansion and new product development to improve future performance[144]. Governance and Management - The company has established a governance structure with a board of directors and supervisory board, overseeing 28 subsidiaries and 8 affiliated companies[171]. - The company appointed Ying Yanzhen as the new general manager and Sun Zhonghai as the deputy general manager, effective from February 7 and March 17, 2017, respectively[103]. - The company has strengthened its management structure and internal control systems to mitigate management risks associated with business upgrades[67]. Risks and Challenges - The company has acknowledged potential risks in its operations and has outlined corresponding countermeasures in the report[4]. - The company faces operational risks due to the expansion of product and service categories, which may challenge its operational capabilities[66]. - The company anticipates increased competition in the internet healthcare sector due to significant investments from various domestic and international firms[66]. Financial Policies and Compliance - The financial report for the first half of 2017 was not audited[132]. - The financial statements are prepared based on the accounting standards issued by the Ministry of Finance and comply with the requirements of the China Securities Regulatory Commission[173]. - The company confirms its ability to continue as a going concern for the next 12 months from the reporting date[176].

Financial Performance - Total revenue for Q1 2017 was ¥55,901,365.53, a decrease of 31.43% compared to ¥81,528,399.20 in the same period last year[7] - Net profit attributable to shareholders was -¥24,553,950.44, representing a decline of 485.92% from -¥4,190,692.58 year-on-year[7] - Basic and diluted earnings per share were both -¥0.0571, down 488.66% from -¥0.0097 in the same period last year[7] - The operating profit for the same period was -32.42 million RMB, reflecting a decline of 352.65% year-over-year[22] - The net profit attributable to shareholders was -24.55 million RMB, down 485.92% from the previous year[22] - The company reported a basic and diluted earnings per share of CNY -0.0571, compared to CNY -0.0097 in the previous period[42] - The net profit for the first quarter of 2017 was -13,574,549.87 CNY, compared to -5,939,134.56 CNY in the same period last year, indicating a significant increase in losses[46] Cash Flow - Net cash flow from operating activities was -¥95,051,593.03, a decrease of 30.58% compared to -¥72,790,251.95 in the previous year[7] - Cash flow from operating activities decreased by 30.58% due to increased payments for commercial factoring and financing leasing[21] - Cash inflow from operating activities totaled 147,493,150.64 CNY, significantly higher than 51,460,003.08 CNY in the same period last year, marking an increase of approximately 186.5%[48] - The cash outflow for operating activities was 242,544,743.67 CNY, compared to 124,250,255.03 CNY in the previous year, indicating an increase of approximately 95.5%[49] - The net cash flow from investment activities was -91,048,280.00 CNY, indicating a significant outflow compared to the previous quarter's -537,788.00 CNY[53] - Cash inflow from financing activities totaled 80,000,000.00 CNY, while cash outflow was 81,550,775.00 CNY, resulting in a net cash flow of -1,550,775.00 CNY[53] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,390,556,364.33, a decrease of 2.00% from ¥1,418,991,298.46 at the end of the previous year[7] - Net assets attributable to shareholders decreased by 3.45% to ¥687,172,059.92 from ¥711,726,010.37 at the end of the previous year[7] - The total assets decreased from 1,418,991,298.46 CNY to 1,390,556,364.33 CNY, a reduction of about 2%[35] - The total liabilities decreased from 674,222,700.49 CNY to 664,675,948.58 CNY, showing a decline of approximately 1.6%[34] - Current liabilities increased to CNY 662,450,597.16 from CNY 581,986,021.73, reflecting a rise of 13.8%[38] Operational Changes - The company faces technology risks due to rapid changes in software and information technology products, necessitating continuous R&D efforts[9] - The company is actively upgrading to an internet operation model to maintain its competitive edge in the industry[11] - The company has established a comprehensive after-sales service system to enhance its brand image and address operational risks[9] - The company is focusing on enhancing its core technology competitiveness through increased investment in talent and R&D[11] Expenses - The company experienced a 40.12% decrease in operating costs year-over-year, correlating with the decline in revenue[22] - Sales expenses increased by 37.71% year-over-year, driven by business expansion efforts[22] - The company incurred total operating expenses of 602,381.27 CNY in sales expenses, down from 796,836.26 CNY, showing a reduction of approximately 24.4%[46] - Management expenses were reported at 13,458,132.80 CNY, a decrease from 16,217,653.18 CNY, indicating a reduction of about 17.2%[46] Investments - Cash flow from investing activities saw a dramatic decrease of 621.83% primarily due to investments in a new associate company[21] - The company reported an investment loss of -1,040,006.32 CNY, compared to -398,291.88 CNY in the previous year, reflecting a worsening in investment performance[46] Shareholder Information - The company distributed a cash dividend of 0.05 CNY per share, totaling 2,150,000 CNY based on a share capital of 43 million shares[26] Miscellaneous - The company has no significant changes in major suppliers or customers during the reporting period[24] - There are no violations regarding external guarantees during the reporting period[27] - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties[28] - The company did not undergo an audit for the first quarter report[55] - The cash flow from operating activities was not detailed in the provided documents, indicating a potential area for further analysis[53]